| Literature DB >> 28486552 |
Qingfen Li1,2, Cheng Deng1, Yan Xia2, Lisheng Kong3, Hanguo Zhang4, Shougong Zhang2, Junhui Wang2.
Abstract
Here, we compared miRNA expression profiles in embryonic cell cultures of the conifer Picea balfouriana following application of the synthetic cytokinin 6-benzylaminopurine (6-BAP). We used next-generation sequencing to analyze three libraries of small RNAs from the treated embryogenic cell cultures and generated 24,000,000 raw reads from each of the libraries. Over 70 differentially regulated micro RNA (miRNA) families (≥2 fold change in expression) were identified between pairs of treatments. A quantitative analysis showed that miR3633 and miR1026 were upregulated in tissues with the highest embryogenic ability. These two miRNAs were predicted to target genes encoding receptor-like protein kinase and GAMYB transcription factors, respectively. In one library, miR1160, miR5638, miR1315, and miR5225 were downregulated. These four miRNAs were predicted to target genes encoding APETALA2, calmodulin-binding protein, and calcium-dependent protein kinase transcription factors. The expression patterns of the miRNAs and their targets were negatively correlated. Approximately 181 potentially novel P. balfouriana miRNAs were predicted from the three libraries, and seven were validated during the quantitative analysis. This study is the first report of differential miRNA regulation in tissues treated with 6-BAP during somatic embryogenesis. The differentially expressed miRNAs will be of value for investigating the mechanisms of embryogenic processes that are responsive to 6-BAP in P. balfouriana.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28486552 PMCID: PMC5423612 DOI: 10.1371/journal.pone.0176112
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Number of mature cotyledonary embryos generated from each 6-BAP treatment and their germination rates.
| 6-BAP concentrations | Mature embryos per 100 mg of embryogenic tissue | Germination rate |
|---|---|---|
| 89 ± 3b | 31.78% ± 0.02b | |
| 113 ± 6a | 48.47% ± 0.03a | |
| 23 ± 2c | 9.42% ± 0.02c |
Superscript letters (a, b, and c) indicate significant differences (p ≤ 0.05).
Fig 1Activities of antioxidant enzymes in 6-BAP-treated tissues in proliferation and maturation stages.
(a) Activity of superoxide dismutase (SOD). (b) Activity of peroxidase (POD). Tissues in proliferation and maturation stages were collected after being transferred to new media for 7 d. Lowercase letters (a, b, c) indicate significant differences (p ≤ 0.05).
Fig 2Levels of plant hormones in 6-BAP-treated tissues in proliferation and maturation stages.
(a) Levels of 3-acetic acid (IAA). (b) Levels of zeatin-riboside (ZR). (c) Levels of gibberellic acid (GA3). (d) Levels of abscisic acid (ABA). Tissues in proliferation and maturation stages were collected after being transferred to new media for 7 d. Lowercase letters (a, b, c) indicate significant differences (p ≤ 0.05).
Fig 3Size distribution analysis of the sRNA sequences in three Picea balfouriana libraries.
Numbers of differentially expressed miRNAs and their targets among the three 6-BAP-treated libraries.
| 2.5 μM vs 5.0 μM | 3.6 μM vs 2.5 μM | 3.6 μM vs 5.0 μM | |
|---|---|---|---|
| 79 | 91 | 87 | |
| 689 | 462 | 547 |
GO analysis and KEGG pathway enrichment of target genes of known miRNAs.
| First | Second | Third | |
|---|---|---|---|
| cell | intracellular | organelle | |
| binding | catalytic activity | hydrolase activity | |
| cellular process | metabolic process | cellular metabolic process | |
| metabolic pathways | spliceosome | RNA transport |
a, b, cFirst, second, and third most abundant terms.
dGO categories.
eKegg pathways.
Predicted novel miRNAs of Picea balfouriana.
| Treatment | Types of predicted miRNAs | Number of miRNAs | Predicted miRNAs | Target sites | Length (nt) | miRNA sequences matched to miRbase |
|---|---|---|---|---|---|---|
| 94 | 86,595 | 70 | 180 | 21 | 18 (6, 33.3%) | |
| 78 | 38,408 | 54 | 144 | 21 | 15 (8, 53.3%) | |
| 77 | 50,498 | 57 | 152 | 21 | 13 (7, 53.8%) |
a. The superscript letter a indicates that the novel miRNA sequence had orthologs in other species
Orthologs of putative novel miRNAs conserved in other species.
| miRNA | Location | Sequence | Length | Count | Homolog | MFE | 5′/3′ |
|---|---|---|---|---|---|---|---|
| 22 | 605 | pta-miR946a | −76.7 | 3 | |||
| 21 | 8 | ath-miR160a | −47.4 | 5 | |||
| 22 | 39 | ath-miR167d | −56.2 | 5 | |||
| 21 | 44 | ptc-miR167f | −59.6 | 3 | |||
| 21 | 6 | zma-miR169r | −53.2 | 3 | |||
| 21 | 11 | ath-miR169b | −51.5 | 5 | |||
| 21 | 22 | aly-miR390a | −50.1 | 3 | |||
| 23 | 129 | mdm-miR391 | −46.1 | 5 | |||
| 22 | 18 | gma-miR482b | −41.1 | 3 |
a. The superscript letter a indicates the location of the miRNA on their precursors.
b. The superscript letter b means minimum free energy.
Expression stability and ranking of reference genes as calculated by geNorm.
| Samples | U6 snRNA | dlo-miR24 | dlo-miR168a* | csi-snoR14 | 5.8S rRNA |
|---|---|---|---|---|---|
| 0.0079 | 0.0232 | 0.0001 | 0.0016 | 1.0000 | |
| 0.0041 | 0.0283 | 0.0001 | 0.0018 | 0.7013 | |
| 0.0056 | 0.0306 | 0.0000 | 0.0014 | 0.9188 | |
| 0.5900 | 0.5370 | 0.7350 | 0.4480 | 0.4750 |
Stability assessment of the candidate reference genes by BestKeeper.
| U6 snRNA | dlo-miR24 | dlo-miR168a* | csi-snoR14 | 5.8Sr RNA | |
|---|---|---|---|---|---|
| 9 | 9 | 9 | 9 | 9 | |
| 30.46 | 28.19 | 36.76 | 32.29 | 23.20 | |
| 30.46 | 28.19 | 36.77 | 32.29 | 23.20 | |
| 29.84 | 27.80 | 35.29 | 31.89 | 22.86 | |
| 31.88 | 28.69 | 37.81 | 32.66 | 24.10 | |
| 0.46 | 0.28 | 0.58 | 0.19 | 0.30 | |
| 1.50 | 0.98 | 1.58 | 0.59 | 1.31 | |
| -1.54 | -1.31 | -2.78 | -1.32 | -1.27 | |
| 2.69 | 1.41 | 2.06 | 1.29 | 1.87 | |
| 1.37 | 1.21 | 1.49 | 1.14 | 1.23 |
Stability assessment of the candidate reference genes by NormFinder.
| Gene name | Stability value |
|---|---|
| 0.3409 | |
| 0.2486 | |
| 0.4729 | |
| 0.1167 | |
| 0.1812 |
Fig 4Validation of differentially regulated miRNAs and their targets by qRT-PCR.
(a)The x-axis shows the miRNAs validated in this study. The y-axis shows the log2 ratio of their expression in the 3.6 μM 6-BAP versus the 5.0 μM 6-BAP libraries. Three biologically independent replicates were analyzed for each qRT-PCR; (b)The x-axis shows the miRNAs validated in this study. The y-axis shows the log2 ratio of their expression in the 3.6 μM 6-BAP versus the 2.5 μM 6-BAP libraries. Three biologically independent replicates were analyzed for each qRT-PCR.